Creative Biolabs offers phage analytics services for researchers who need to characterize a bacteriophage, compare preparations, investigate phage-host behavior, or examine attributes relevant to research quality control. Phage analysis is most useful when each method is selected for a defined question. Genome sequencing, infectious titer, particle-related measurement, host range, stability, and impurity assessment describe different properties; none of them alone provides a complete description of identity, activity, or suitability.
Our analytical support spans genetic, biological, structural, biochemical, and immunological areas where appropriate to the current study. The same test panel is not applied to every phage. A newly isolated phage, an engineered construct, a production batch, and a formulation study each require different evidence. We help customers distinguish essential measurements from optional information, while avoiding a project-specific recommendation until the phage type, sample condition, host system, and intended research decision are understood.
Our services are listed as follows, but are not limited to:
Biophysical Analysis: Creative Biolabs has long been committed to the development of phage biophysical analysis methods, and the analysis services include high-quality phage detection and phage-host interaction prediction and interaction analysis services
Biochemical Analysis: We provide biochemical analysis services. Biochemical analysis is designed to conduct comprehensive quantitative and qualitative analyses of biomolecules in biological processes or systems.
Genetic Analysis: Creative Biolabs is good at applying advanced phage gene analysis technology to a wide range of project goals. Our scientists can provide phage metagenomic sequencing services and RNA sequencing services.
Immunological Analysis: Immunogenicity testing plays a vital role in immune responses during the development of phage therapy. Creative Biolabs provides unique immunogenicity assay development and verification based on system MSD and ELISA quantitative.
The analytical question changes as a phage project develops. Early discovery may focus on confirming plaque formation, host association, morphology, or genome identity. Engineering work often adds sequence confirmation and comparison with a parental phage. Production studies may examine recovery, infectious titer, particle concentration, host-derived material, and stability. Application studies may require host range, adsorption, growth-related behavior, or assay-specific performance. These measurements should be selected because they inform a decision, not because they are routinely included in a broad panel.
Method context is equally important. Titer values depend on the host, assay format, plating conditions, and calculation approach. Genome data depend on sample quality, sequencing coverage, assembly, and annotation criteria. Stability results depend on formulation, handling, time, and the measured endpoint. Creative Biolabs reports analytical results with the conditions needed for interpretation. Where methods answer related but non-equivalent questions, we keep the results separate instead of combining them into a single quality claim.
Match the analytical question to the measurement
| Project question | Representative measurement | Key interpretation |
|---|---|---|
| Is the intended phage present? | Genome identity, marker assay, sequencing, or protein/particle identity | Identity evidence should be distinguished from quantity or infectivity. |
| How much active phage is available? | Plaque assay, spot assay, endpoint method, or another infectivity-based titer | Method, host state, plating format, and counting rules affect comparability. |
| Which hosts are affected? | Host range panel, efficiency-of-plating comparison, or liquid-kill assay | A positive spot does not by itself establish productive infection; follow-up design matters. |
| Will the material remain usable? | Short-term stability, freeze-thaw, temperature, or buffer study | The study should match anticipated storage, shipment, concentration, and handling. |
Sample and method planning inputs
Phage genome analysis may include nucleic-acid extraction, sequencing, assembly, annotation, and comparative assessment, depending on the material and study objective. Sequence information can help confirm identity, define genome organization, examine an engineered region, or identify features that warrant further review. Annotation is an evidence-based interpretation rather than a complete statement of biological function. Many predicted genes remain hypothetical, and sequence similarity alone cannot establish phenotype.
For engineered phages, analysis should cover the intended edit and the surrounding sequence context needed to interpret it. For newly isolated phages, assembly quality and terminal or repetitive regions may require special attention. Comparative genomics can show relationships to reference phages and highlight conserved or divergent regions, but conclusions depend on the available databases and comparison set. Our scientists present these limitations with the results so customers can judge which findings are established and which remain candidates for further research.
Genome analysis outputs
| Identity and completeness Assembly and coverage review can assess whether the recovered sequence matches the intended phage and whether unresolved regions require additional confirmation. | Feature annotation Open reading frames, structural modules, lysis-related functions, integration-associated elements, and other annotated features provide a structured basis for project-specific review. | Comparative context Similarity, phylogenetic, or gene-content comparisons can position a phage among related isolates and identify regions that deserve closer interpretation. |
|---|
Biological characterization examines how a phage behaves in a defined host and assay system. Plaque assay, spot testing, host-range studies, adsorption-related measurements, one-step growth analysis, and sensitivity or stability assays can address infectivity and phage-host interaction from different angles. A clearing zone in a spot test alone does not establish efficient productive infection. Confirmation with an assay that measures recoverable progeny may be needed when that distinction matters to the study.
Host range is also conditional. Results can vary with bacterial strain, growth state, receptor expression, medium, and assay design. Creative Biolabs therefore avoids describing a phage as broadly active without the tested panel and method context. When several biological measurements are included, their value comes from how they complement one another. Infectious titer may establish activity under one condition, while adsorption or growth-related data help explain why activity differs among hosts or preparations.
Biological characterization modules
| Module | What it examines | Planning note |
|---|---|---|
| Titer and potency | Infectious units or activity across defined host conditions | Use the same host, medium, timing, and calculation rules for comparisons. |
| Host range | Activity across strains, species, or phenotypic groups | Separate spot formation, productive infection, and relative plating efficiency where needed. |
| Growth behavior | Adsorption, latent period, burst-related behavior, or time-kill pattern | Select an assay model that reflects the biological question rather than collecting all endpoints by default. |
| Resistance response | Emergence and characterization of less-susceptible bacterial populations | Interpret with controls and consider receptor, fitness, and cross-resistance questions. |
Fig.1 Representative automated drop-off plates showing serial phage dilutions, missing or merged drops, and distinct plaque morphologies.1
Structural assessment may examine particle morphology, size, integrity, aggregation, or other physical attributes using methods appropriate to the sample and question. These observations can help distinguish intact particles from debris or reveal changes associated with preparation and storage. They do not replace infectivity testing. A sample may contain recognizable particles with reduced biological activity, while an infectious preparation may still show heterogeneity that matters for another application.
Functional assessment is defined by what the phage is expected to do in the research system. This may involve host interaction, receptor-related behavior, display function, reporter output, or another project-specific endpoint. The assay must separate the intended activity from non-specific effects and include suitable controls. Creative Biolabs discusses functional testing only after the biological question and available model are clear; a suitable assay or expected result is not inferred from the phage name alone.
Complementary analytical views
| Particle view Microscopy, particle-related quantification, and morphology assessment describe physical material but should not be equated automatically with infectious activity. | Function view Binding, adsorption, lysis, biofilm, time-kill, or combination studies test a defined biological function under a specified model. | Quality view Endotoxin, residual host material, bioburden, concentration, appearance, and stability provide context for research use and downstream assay compatibility. |
|---|
Phage quality control for research may combine identity, concentration, infectious titer, purity-related attributes, formulation information, and stability measurements. The appropriate combination depends on whether the material will be used for screening, comparative biology, formulation research, assay development, or another laboratory purpose. Genome copies, particle counts, and plaque-forming units measure different populations. Reporting their context is more informative than treating one value as a universal measure of quality.
Impurity and stability considerations are also use dependent. Host-cell material, endotoxin, bioburden, aggregation, buffer composition, or loss of infectivity may matter in some projects and not in others. No fixed acceptance limit is stated unless it has been established for the specific research scope. Our role is to perform and document agreed analyses accurately, identify method limitations, and help customers interpret whether the data answer the stated research question.
Creative Biolabs organizes phage characterization around linked questions: what the phage is, whether it is active in the tested system, how the particles and preparation are constituted, and how these attributes change under relevant conditions. Customers may request an individual analysis or discuss a combined study when several measurements are needed to interpret one another. The service remains modular so unnecessary testing is not presented as a requirement.
To discuss a phage analysis service, researchers can provide the available phage description, host information, sample state, and the question the data must resolve. Creative Biolabs will identify suitable analytical categories and any information gap that prevents responsible method selection. No claim is made that a test panel will establish safety, efficacy, clinical utility, or regulatory suitability; all services and interpretations are intended for research use.
Integrated phage analytics data package
| Layer | Included evidence | Value to the project |
|---|---|---|
| Method context | Sample history, host, controls, protocol version, and calculation rules | Makes results traceable and prevents comparisons across incompatible conditions. |
| Primary results | Tables, curves, images, sequences, plate maps, or instrument outputs as scoped | Provides the direct observations behind the interpretation. |
| Interpretation | Limits, anomalies, repeat findings, and decision-relevant comparisons | Shows what the data can and cannot support for the next research step. |
| Handoff | Summary report, agreed raw files, and retained-sample disposition | Supports internal review, follow-on testing, and reproducible project continuity. |
1. Dufour, Nicolas, Raphaëlle Delattre, and Laurent Debarbieux. “High-Throughput Bacteriophage Testing with Potency Determination: Validation of an Automated Pipetting and Phage Drop-Off Method." Biomedicines 12.2 (2024): 466. Distributed under Open Access license CC BY 4.0. https://doi.org/10.3390/biomedicines12020466.
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
